Vimarsana
Biggest News Aggregation in the World

Page 5 - Pathogenesis Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pathogenesis Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pathogenesis Program Today - Breaking & Trending Today

HealthNewsDigest.com - Vimarsana News

HealthNewsDigest.com

(HealthNewsDigest.com) - LA JOLLA, CALIF. – April 16, 2021 – Scientists at Sanford Burnham Prebys have identified a set of human genes that fight SARS-CoV-2 infection, the virus that causes COVID-19. Knowing which genes help control viral infection can greatly assist researchers’ understanding of factors that affect disease severity and also suggest possible therapeutic options. The genes in question are related to interferons, the body’s frontline virus fighters. The study was published in the journal  “We wanted to gain a better understanding of the cellular response to SARS-CoV...

Researchers led by Indian-origin scientist identify genes that fight virus causing COVID-19 - Vimarsana News

Researchers led by Indian-origin scientist identify genes that fight virus causing COVID-19

Researchers led by Indian-origin scientist identify genes that fight virus causing COVID-19 SECTIONS Last Updated: Apr 17, 2021, 12:25 PM IST Share Synopsis The study by scientists at Sanford Burnham Prebys Medical Discovery Institute in San Diego, California, was published in the journal Molecular Cell. Agencies As a next step, the researchers will look at the biology of SARS-CoV-2 variants that continue to evolve and threaten vaccine efficacy. US researchers led by an Indian-origin scientist have identified a set of human genes that fight SARS-CoV-2, the virus which causes COVID-19, a study...

COVID-19: Scientists identify human genes that fight infection - Vimarsana News

COVID-19: Scientists identify human genes that fight infection

Credit: Dotted Yeti LA JOLLA, CALIF. - April 16, 2021 - Scientists at Sanford Burnham Prebys have identified a set of human genes that fight SARS-CoV-2 infection, the virus that causes COVID-19. Knowing which genes help control viral infection can greatly assist researchers' understanding of factors that affect disease severity and also suggest possible therapeutic options. The genes in question are related to interferons, the body's frontline virus fighters. The study was published in the journal Molecular Cell. "We wanted to gain a better understanding of the cellular response to SARS-CoV...

Leprosy drug holds promise as at-home treatment for COVID-19 - Vimarsana News

Leprosy drug holds promise as at-home treatment for COVID-19

 E-Mail IMAGE: Sumit Chanda, co-senior study author and director of the Immunity and Pathogenesis Program at Sanford Burnham Prebys. view more  Credit: Sanford Burnham Prebys Medical Discovery Institute LA JOLLA, CALIF. - March 16, 2021 - A Nature study authored by scientists at Sanford Burnham Prebys Medical Discovery Institute and the University of Hong Kong shows that the leprosy drug clofazimine, which is FDA approved and on the World Health Organization's List of Essential Medicines, exhibits potent antiviral activities against SARS-CoV-2 and prevents the exaggerated inflammat...

Brain Trust: 8 Questions with Ingo Mellinghoff - Vimarsana News

Brain Trust: 8 Questions with Ingo Mellinghoff

Summary Neuro-oncologist Ingo Mellinghoff first became intrigued by scientific questions regarding brain tumors while working in the lab of physician-scientist Charles Sawyers before both came to MSK. Now, Dr. Mellinghoff leads MSK’s Department of Neurology as it deploys innovative technologies to understand how these cancers develop and progress. When neuro-oncologist Ingo Mellinghoff was named Chair of Memorial Sloan Kettering’s Department of Neurology in October 2020, it marked the culmination of a career devoted to studying how cancer affects the brain. Dr. Mellinghoff previously ser...

Source: mskcc.org